Literature DB >> 18435789

Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.

Stanley T S Tjoa1, Teun J de Vries, Ton Schoenmaker, Angele Kelder, Bruno G Loos, Vincent Everts.   

Abstract

AIM: To determine whether peripheral blood mononuclear cells (PBMCs) from chronic periodontitis patients differ from PBMCs from matched control patients in their capacity to form osteoclast-like cells.
MATERIAL AND METHODS: PBMCs from 10 subjects with severe chronic periodontitis and their matched controls were cultured on plastic or on bone slices without or with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappaB ligand (RANKL). The number of tartrate-resistant acid phosphatase-positive (TRACP(+)) multinucleated cells (MNCs) and bone resorption were assessed.
RESULTS: TRACP(+) MNCs were formed under all culture conditions, in patient and control cultures. In periodontitis patients, the formation of TRACP(+) MNC was similar for all three culture conditions; thus supplementation of the cytokines was not needed to induce MNC formation. In control cultures, however, M-CSF or M-CSF/RANKL resulted in higher numbers compared with cultures without cytokines. Upregulations of osteoclast marker mRNA cathepsin K and carbonic anhydrase II confirmed the osteoclastic character. Bone resorption was only observed when PBMCs were cultured in the presence of M-CSF and RANKL.
CONCLUSION: Our data indicate that PBMCs from periodontitis patients do not need priming by M-CSF to become osteoclast-like cells, suggesting that PBMCs from periodontitis patients are present in the circulation in a different state of activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435789     DOI: 10.1111/j.1600-051X.2008.01241.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.

Authors:  W He; B N Cronstein
Journal:  Purinergic Signal       Date:  2012-02-05       Impact factor: 3.765

Review 2.  Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Authors:  Corneliu Sima; Ana Viniegra; Michael Glogauer
Journal:  J Leukoc Biol       Date:  2018-11-19       Impact factor: 4.962

3.  Alendronate reduces osteoclast precursors in osteoporosis.

Authors:  P D'Amelio; A Grimaldi; M A Cristofaro; M Ravazzoli; P A Molinatti; G P Pescarmona; G C Isaia
Journal:  Osteoporos Int       Date:  2009-12-01       Impact factor: 4.507

4.  Effects of oestrogen deficiency on the alveolar bone of rats with experimental periodontitis.

Authors:  Xin-Chen Xu; Hui Chen; Xi Zhang; Zan-Jing Zhai; Xu-Qiang Liu; Xin-Yi Zheng; Jun Zhang; An Qin; Er-Yi Lu
Journal:  Mol Med Rep       Date:  2015-06-02       Impact factor: 2.952

Review 5.  What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss?

Authors:  Teun J de Vries; Ismail El Bakkali; Thomas Kamradt; Georg Schett; Ineke D C Jansen; Patrizia D'Amelio
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 6.  Periodontal disease: linking the primary inflammation to bone loss.

Authors:  Adriana Di Benedetto; Isabella Gigante; Silvia Colucci; Maria Grano
Journal:  Clin Dev Immunol       Date:  2013-05-23

7.  Enhanced dual function of osteoclast precursors following calvarial Porphyromonas gingivalis infection.

Authors:  Xia Cai; Zhaofei Li; Yanfang Zhao; Jenny Katz; Suzanne M Michalek; Xu Feng; Yuhong Li; Ping Zhang
Journal:  J Periodontal Res       Date:  2020-01-16       Impact factor: 4.419

8.  Effect of Enamel Matrix Derivatives on Osteoclast Formation from PBMC of Periodontitis Patients and Healthy Individuals after Interaction with Activated Endothelial Cells.

Authors:  Gerlinde Durstberger; Phuong Quynh Nguyen; Verena Hohensinner; Peter Pietschmann; Xiaohui Rausch-Fan; Oleh Andrukhov
Journal:  Medicina (Kaunas)       Date:  2021-03-15       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.